Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Yoshiyuki Takahashi"'
Autor:
Hideki Muramatsu, Yusuke Okuno, Motoharu Hamada, Seiji Kojima, Atsushi Narita, Norihiro Murakami, Mignon L. Loh, Kotaro Narita, Daisuke Ichikawa, Elliot Stieglitz, Manabu Wakamatsu, Hironobu Kitazawa, Asahito Hama, Nozomu Kawashima, Rieko Taniguchi, Kyogo Suzuki, Shinsuke Kataoka, Yoshiyuki Takahashi, Nobuhiro Nishio, Eri Nishikawa, Kosuke Aoki
Publikováno v:
Blood Advances
Blood advances, vol 5, iss 24
Blood advances, vol 5, iss 24
Key Points A total of 137 patients with JMML were analyzed using DREAM.We developed a robust DNA methylation test that is highly consistent with the array-based international consensus definition for JMML.
Visual Abstract
Juvenile myelomono
Visual Abstract
Juvenile myelomono
Autor:
Maho Sato, Tomohiro Morio, Hiromasa Yabe, Akira Nishimura, Koji Kato, Yoshiyuki Takahashi, Masami Inoue, Satoshi Miyamoto, Takashi Koike, Akihiro Iguchi, Kohsuke Imai, Tomonari Shigemura, Yoshiko Atsuta, Yoji Sasahara, Michiko Kajiwara, Masakatsu Yanagimachi, Motohiro Kato, Yoshiko Hashii, Mio Kurata, Masataka Ishimura, Katsutsugu Umeda
Publikováno v:
Journal of Clinical Immunology
Purpose Hematopoietic cell transplantation (HCT) is a curative therapy for patients with severe combined immunodeficiency (SCID). Here, we conducted a nationwide study to assess the outcome of SCID patients after HCT in Japan. Methods A cohort of 181
Autor:
Asahito Hama, Nozomu Kawashima, Motoharu Hamada, Nobuhiro Nishio, Seiji Kojima, Eri Nishikawa, Shinji Nakao, Yusuke Okuno, Daisuke Ichikawa, Hideki Muramatsu, Kyogo Suzuki, Hirohito Yamazaki, Yoshiyuki Takahashi, Atsushi Narita
Publikováno v:
European Journal of Haematology. 107:255-264
Objectives Patients with acquired aplastic anemia (AA) without HLA-matched sibling donors or aged >40 years receive immunosuppressive therapy (IST) with anti-thymocyte globulin (ATG). We investigated the relationship between plasma rabbit ATG (r-ATG)
Autor:
Yuichi Ishikawa, Tatsunori Goto, Katsuyoshi Kato, Tetsuya Nishida, Yoshiyuki Takahashi, Sonoko Kamoshita, Seitaro Terakura, Akihiro Hirakawa, Hitoshi Kiyoi, Nobuhiro Nishio, Satoshi Nishiwaki, Yoko Ushijima, Makoto Murata, Yoshiya Adachi, Tadashi Matsushita, Yoshihisa Kodera, Satoshi Suzuki
Publikováno v:
Stem Cells Translational Medicine
Stem Cells Translational Medicine, Vol 10, Iss 4, Pp 542-553 (2021)
Stem Cells Translational Medicine, Vol 10, Iss 4, Pp 542-553 (2021)
Mesenchymal stem cells (MSCs) have immunomodulatory properties and support hematopoiesis in the bone marrow (BM). To develop a new strategy to not only prevent graft‐vs‐host disease (GVHD) but also to enhance engraftment, a phase I trial of cord
Autor:
Yoshihiro Kushida, Masahiro Tsuji, Toshihiko Suzuki, Masahiro Hayakawa, Yukako Iitani, Shigeyoshi Saito, Yoshiyuki Takahashi, Mari Dezawa, Kenji Imai, Cesar V. Borlongan, Shinobu Shimizu, Hideki Hida, Masaaki Mizuno, Takashi Temma, Shohei Wakao, Hidehiro Iida, Kazuto Ueda, Yoshiaki Sato
Publikováno v:
Journal of Cerebral Blood Flow & Metabolism
Perinatal hypoxic ischemic encephalopathy (HIE) results in serious neurological dysfunction and mortality. Clinical trials of multilineage-differentiating stress enduring cells (Muse cells) have commenced in stroke using intravenous delivery of donor
Autor:
Masaki Yamamoto, Satoru Miyano, Hideki Muramatsu, Seishi Ogawa, Hitoshi Kanno, Yuki Yuza, Yoji Sasahara, Etsuro Ito, Seiji Kojima, Hiromasa Yabe, Nobuyuki Hyakuna, Shouichi Ohga, Daiichiro Hasegawa, Kenichi Yoshida, Masanori Nishi, Takuya Kamio, Takeo Sarashina, Harumi Kakuda, Akira Ishiguro, Yoshiyuki Takahashi, Kiminori Terui, Tomohiko Sato, Tsutomu Toki, Akie Kobayashi, Masataka Ishimura, Rika Kanezaki, Hidefumi Hiramatsu, Akira Ohara, Miyuki Tanaka, Shinya Sasaki, Ko Kudo, Shun Koyamaishi
Publikováno v:
Bone Marrow Transplantation. 56:1013-1020
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative therapy for the hematologic manifestations of Diamond–Blackfan anemia (DBA). However, data regarding the optimal conditioning regimen for DBA patients are limited. We re
Autor:
Yousuke Nakai, Tatsuya Matsuno, Akira Toyoshima, Kazuhiko Koike, Kosuke Sakitani, Masatoshi Irokawa, Shuntaro Yoshida, Tomoharu Yamada, Toshihiro Nishizawa, Yoshiyuki Takahashi, Osamu Toyoshima
Publikováno v:
World Journal of Gastrointestinal Endoscopy. 12:276-284
Kyoto classification in patients who developed multiple gastric carcinomas after Helicobacter pylori eradication
Autor:
Toshiyuki Fukao, Hideki Muramatsu, Hidenori Ohnishi, Asahito Hama, Saori Endo, Shiho Yasue, Yoshiyuki Takahashi, Akifumi Nozawa, Michio Ozeki, Tomonori Kadowaki, Seiji Kojima
Publikováno v:
International Journal of Hematology. 112:728-733
Few hematological complications have previously been reported in association with Cri du Chat syndrome (CdCS). A case of myelodysplastic syndromes (MDS) in a pediatric patient with CdCS is herein presented. A 17-year-old female with CdCS caused by ri
Autor:
Hiroyuki Shimada, Koji Kato, Nao Yoshida, Yoshiko Atsuta, Maho Sato, Hirotoshi Sakaguchi, Yuko Cho, Daisuke Hasegawa, Katsuyoshi Koh, Motohiro Kato, Kenichiro Watanabe, Yoshiko Hashii, Harumi Kakuda, Yoshiyuki Takahashi, Asahito Hama, Maiko Noguchi, Daiichiro Hasegawa, Kiminori Terui, Miharu Yabe, Atsushi Sato
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:902-910
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for juvenile myelomonocytic leukemia (JMML), but few large studies of HSCT for JMML exist. Using data from the Japan Society for Hematopoietic Cell Transplantation registry
Autor:
Kazuhiko Koike, Kosuke Sakitani, Osamu Toyoshima, Kazunori Kinoshita, Akira Torii, Toshihiro Nishizawa, Hidekazu Suzuki, Yoshiyuki Takahashi, Atsuo Yamada, Tadahiro Yamakawa
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open, Vol 4, Iss 5, Pp 909-914 (2020)
JGH Open, Vol 4, Iss 5, Pp 909-914 (2020)
Background and Aim Endoscopy‐based Kyoto classification predicts the risk of Helicobacter pylori infection and gastric cancer; however, the change in score following H. pylori eradication remains unknown. We retrospectively compared the Kyoto score